Jiangsu Pulurui Medical Technology - AI data backend can use the AI platform to unlock complex genomic data, such as gene expression patterns of diseases, which can bring about a revolution in drug development, clinical research, and medical treatment. By combining human and machine intelligence, it simplifies the discovery of disease-related biology, thereby shortening discovery time and significantly increasing the probability of success. Artificial intelligence and its subsets, machine learning and deep learning, are well suited for mining large amounts of genotypic and phenotypic data derived from global and public and private databases, hospitals and doctors' offices, academic research journals, and personal wearable health monitoring devices. AI transforms drug research from a hypothesis-driven to a data-driven process. The time required from project initiation to candidate drug discovery using AI for drug R&D is only a quarter of the average time in the pharmaceutical R&D industry. AI drug design can bring far-reaching strategic advantages and also provide data support for various branches under the group.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows